Berlin
08.09.25 | 08:31
0,254 Euro
0,00 % 0,000
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18.08. | XFRA 31B: AUSSETZUNG/SUSPENSION | 146 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILBENCHMARK HLDGS... ► Artikel lesen | |
| 18.08. | AIM - Cancellation - BENCHMARK HOLDINGS PLC | 1 | RNS | ||
| 15.08. | Benchmark Holdings plc - Last day of trading | 1 | Oslo Børs | ||
| 08.08. | Benchmark Holdings plc: Update on Euronext Oslo Børs approval of the cancellation of the trading of Benchmark's shares from Euronext Growth Oslo and the cancellation of trading of the Company's shares on AIM | 1 | Oslo Børs | ||
| 08.08. | Benchmark Holdings plc - Decision on date of delisting | 1 | Oslo Børs | ||
| 31.07. | Benchmark Holdings plc: Total Voting Rights | 2 | Oslo Børs | ||
| BENCHMARK HOLDINGS Aktie jetzt für 0€ handeln | |||||
| 25.07. | Benchmark Holdings plc: Correction: Result of Tender Offer, Total Voting Rights and Directors' Interests | - | Oslo Børs | ||
| 25.07. | Benchmark Holdings plc: Result of Tender Offer, Total Voting Rights and Directors' Interests | 1 | Oslo Børs | ||
| 22.07. | Russian Fishery Company elevates CEO Saveliy Karpukhin to chairman; Benchmark Holdings names Patrick Waty new CEO | 1 | SeafoodSource | ||
| 21.07. | Benchmark Holdings plc: Board and Management Changes | 1 | Oslo Børs | ||
| 01.07. | Benchmark Holdings plc: Update on Conditions, Opening of Tender Offer and Expected Timetable | 1 | Oslo Børs | ||
| 30.06. | Benchmark Holdings plc: Total Voting Rights | 1 | Oslo Børs | ||
| 27.06. | Benchmark Holdings plc - Delisting | 8 | Oslo Børs | ||
| 20.06. | Benchmark Holdings plc: Received application for delisting | 1 | Oslo Børs | ||
| 18.06. | Benchmark Holdings plc: Result of GM | - | Oslo Børs | ||
| 12.06. | Benchmark Holdings Halbjahresergebnisse: Verkauf der Genetics-Sparte stärkt Kasse trotz Umsatzrückgang | - | Investing.com Deutsch | ||
| 12.06. | Benchmark Holdings reports drop in revenue, confirms delisting plans | 1 | Alliance News | ||
| 12.06. | Benchmark Holdings plc: Half year results for the six months ended 31 March 2025 | 3 | Oslo Børs | ||
| 03.06. | Benchmark Holdings plc: TR-1: Standard form for notification of major holdings | 1 | Oslo Børs | ||
| 02.06. | Benchmark Holdings plc: Rule 2.9 Announcement and Total Voting Rights | 2 | Oslo Børs |
1 2 Weiter >>
34 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 28,030 | -0,73 % | Bayer-Aktie leicht im Plus (28,835 €) | Im Plus liegt aktuell die Bayer-Aktie . Zuletzt zahlten Investoren für die Aktie 28,84 Euro. Freuen können sich gegenwärtig die Aktionäre von Bayer: Das Wertpapier weist derzeit eine Verteuerung von... ► Artikel lesen | |
| NOVO NORDISK | 46,470 | +0,06 % | Hoffnung im Alzheimer-Kampf: Kann Ozempic Demenz bremsen? Novo riskiert Milliarden-Wette | © Foto: Jakub Porzycki - NurPhotoNovo Nordisk testet, ob seine Ozempic-Pille auch bei Alzheimer wirkt. Gelingt der Durchbruch, winkt ein Milliardenmarkt. Doch Experten warnen: Das Risiko ist enorm,... ► Artikel lesen | |
| GSK | 17,270 | -0,14 % | Research and Markets: Europe Liver Disease Therapeutic Market Analysis Report 2025-2033 Featuring Abbott, Astellas, BMS, Gilead Sciences, GSK, F. Hoffman-La Roche, Merck, Novartis, Sanofi, Pfizer, Takeda - ResearchAndMarkets.com | The "Europe Liver Disease Therapeutic Market Forecast 2025" report has been added to ResearchAndMarkets.com's offering.
The Europe Liver Disease Therapeutic Market is expected to grow from US$... ► Artikel lesen | |
| HALO COLLECTIVE | 0,010 | 0,00 % | Waters Corporation Buys Halo Labs | WASHINGTON (dpa-AFX) - Waters Corporation (WAT), an analytical instruments and software firm, said on Wednesday that it has acquired Halo Labs, a company focused on specialized imaging technologies... ► Artikel lesen | |
| INNOCAN PHARMA | 7,685 | +1,28 % | XFRA ISIN CHANGE | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenCA45783P1027 InnoCan Pharma Corp. 04.09.2025 CA45783P5085 InnoCan Pharma Corp. 05.09.2025 Tausch 65:1US63911H2076 Nauticus... ► Artikel lesen | |
| EYEPOINT PHARMACEUTICALS | 11,635 | +0,39 % | EyePoint Pharmaceuticals, Inc.: EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | WATERTOWN, Mass., Aug. 18, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients... ► Artikel lesen | |
| EDWARDS LIFESCIENCES | 66,93 | +0,04 % | Edwards Lifesciences Corporation: Updated ESC/EACTS Guidelines Mark Advancement in Structural Heart Disease Care | Edwards Lifesciences (NYSE: EW) welcomes the updated ESC/EACTS guidelines for valvular heart disease, which establish a simplified care pathway for all severe aortic stenosis (AS) patients, regardless... ► Artikel lesen | |
| WPD PHARMACEUTICALS | 0,002 | 0,00 % | WPD Pharmaceuticals Inc (2): WPD Pharmaceuticals suspended by CSE | ||
| MYDECINE INNOVATIONS GROUP | 0,002 | 0,00 % | Aquis Stock Exchange: Withdrawal from Trading - Mydecine Innovations Group Inc. | Aquis Stock Exchange
Aquis Stock Exchange: Withdrawal from Trading 02-Apr-2025 / 07:00 GMT/BST
The issuer is solely responsible for the content of this... ► Artikel lesen | |
| HAPPY BELLY FOOD GROUP | 0,700 | +0,72 % | Happy Belly Food Group Inc.: Happy Belly Food Group Appoints Vice President of Finance | Toronto, Ontario--(Newsfile Corp. - September 8, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leading consolidator of emerging food brands is pleased... ► Artikel lesen | |
| CHRISTINA LAKE CANNABIS | 0,019 | +111,11 % | Christina Lake Cannabis Corp.: Christina Lake Cannabis Announces Debenture Extension | VANCOUVER, British Columbia, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Christina Lake Cannabis Corp. (the "Company" or "CLC" or "Christina Lake Cannabis") (CSE: CLC) (OTCQB: CLCFF) (FRANKFURT: CLB) announces... ► Artikel lesen | |
| BETTER PLANT SCIENCES | 0,023 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 28.05.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 28.05.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 28.05.2025ISIN NameBMG3728V1090 GAN... ► Artikel lesen | |
| PSYCHED WELLNESS | 0,006 | +200,00 % | Psyched Wellness Ltd.: Psyched Wellness Provides Comprehensive Investor Update | Toronto, Ontario--(Newsfile Corp. - April 10, 2025) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched"), a life sciences company focused on the production and... ► Artikel lesen | |
| JAZZ PHARMACEUTICALS | 108,25 | -1,32 % | Jazz Pharmaceuticals plc: Modeyso (dordaviprone) Included in National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology for H3 K27M-mutant Diffuse Glioma | Modeyso, the first treatment option for this ultra-rare and aggressive brain tumor, is commercially available in the United States
For U.S. media and investors... ► Artikel lesen | |
| DAIICHI SANKYO | 20,680 | +0,19 % | Daiichi Sankyo And Merck: Ifinatamab Deruxtecan Shows Promising Results In Phase 2 ES-SCLC Trial | KENILWORTH (NJ) (dpa-AFX) - Daiichi Sankyo (DSKYF, 4568.T) and Merck & Co Inc. (MRK) announced that Results from the IDeate-Lung01 phase 2 trial showed that ifinatamab deruxtecan (I-DXd) demonstrated... ► Artikel lesen |
Das Unternehmen BENCHMARK HOLDINGS PLC kann der Branche Pharma zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,254 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BENCHMARK HOLDINGS PLC finden Sie auf Wallstreet Online.